Armin Schulz
Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.
After graduating, he worked as an IT consultant for a listed company before becoming self-employed, during which time he worked for various DAX-listed companies and a large Swiss insurance company, among others.
Since 2009, he has been exclusively involved in the capital markets, where he was able to gain experience as a day and swing trader, in investor relations and at board level. He was able to live out his passion for numbers in the controlling department of a securities trading house.
For him, fundamental analysis paired with the correct reading of the price action of a market provides the basis for successful trading.
Commented by Armin Schulz
Commented by Armin Schulz on March 23rd, 2022 | 12:01 CET
Rheinmetall, Kleos Space, Lufthansa - Which shares benefit from the war-related supply chain problems?
Supply chain problems began in earnest with Corona, and just when it seemed the situation was returning to normal, the Ukraine conflict started. We are already seeing the effects in the supermarket today. Once again, no toilet paper, and you also have to be lucky with cooking oil, pasta and flour. But the industry is also suffering, with the automotive, pharmaceutical and chemical sectors being particularly affected. It is not only due to a lack of materials but also to longer transport routes, as Russia, for its part, has closed its airspace to foreign machinery. Imports from China thus have a longer route - the only alternative remains shipping, which in turn is significantly slower.
Read
Commented by Armin Schulz on March 21st, 2022 | 10:08 CET
TUI, Desert Gold, Steinhoff - Cheap Shares, bargain hunters watch out
Today, we look at three companies whose share prices appear cheap at first glance and then analyze which candidates have potential. An affordable stock is not necessarily cheap, just as an expensive stock is not automatically expensive. The problem with many retail investors is that they do not have the money to buy a few Amazon shares. Therefore, smaller stocks are more likely to be found, especially in smaller portfolios. One should look at the market sentiment of a company and its fundamentals to avoid betting on the wrong horse if possible.
Read
Commented by Armin Schulz on March 18th, 2022 | 12:30 CET
Plug Power, dynaCERT, Nel ASA - Hydrogen market worth billions
The German government wants to become independent of Russian energy imports as soon as possible. One way to achieve this could be green hydrogen. Markus Söder recently called for more hydrogen pipelines to be built quickly. It is no wonder as it is a long way from wind farms in the north or ports in the Netherlands to Bavaria. Interest in hydrogen in Europe is high. The EU Commission wants to increase hydrogen production to 25 gigawatts by 2030. Already in February Goldman Sachs drew attention to the hydrogen topic. It considers hydrogen to be an important factor on the way to a zero-emission economy and expects the industry to grow strongly. The Ukraine crisis gives a corresponding tailwind.
Read
Commented by Armin Schulz on March 16th, 2022 | 11:04 CET
K+S, MAS Gold, Hensoldt - Shares around fertilizers, gold and armaments on the upswing
Even in times of crisis, there are always winners. In the case of the Ukraine crisis, these are the fertilizer producers due to the lack of wheat from Russia and Ukraine. With their fertilizers, wheat producers are trying to at least partially meet the excess demand. Gold managed to break out on the upside after the war began and is still considered a safe haven. Last but not least, of course, the defense industry is benefiting from the war drive. Today, we take a look at one company from each sector.
Read
Commented by Armin Schulz on March 14th, 2022 | 11:24 CET
BASF, Globex Mining, Deutsche Post - Undervalued stocks belong in the portfolio
At the moment, there are many hot spots on the stock exchange, not only the Ukraine crisis, inflation or the Corona pandemic but also the expected interest rate hikes. The latter are announced for next Wednesday, March 16. But will the rate hike come while the Ukraine conflict is smoldering? Embargoes of the Western countries burden their own economy, and at the same time, Russia threatens with a stop of energy exports, which are partially not yet suspended. The Corona numbers are rising again, and Karl Lauterbach has warned of a summer wave. Inflation is rising all the time. All these factors have caused some stocks to collapse that are worth investing in now. We take a look at three stocks that we believe are undervalued.
Read
Commented by Armin Schulz on March 11th, 2022 | 11:19 CET
Rheinmetall, Triumph Gold, Siemens Energy - Safe havens despite the crisis?
The Ukraine crisis finally broke the camel's back. Previously, neither the announcement of interest rate hikes nor galloping inflation could move the stock markets to a proper correction. With the beginning of the Russia attack on Ukraine, the indices have lost significant value. Mutual economic embargoes weaken each other, and in the end, the consumer will pay the bill. But as in every crisis, there are winners. Weapons manufacturers are suddenly booming, the price of gold has soared, and renewable energies are being given extra support to ensure independence from Russian energy imports. Today, we look at one company from each of the three sectors.
Read
Commented by Armin Schulz on March 9th, 2022 | 13:14 CET
BP, Saturn Oil + Gas, Shell - Oil as the winner of the crisis
There are increasing signs that the EU wants to free itself from Russian oil and gas supplies as quickly as possible. Bloomberg writes that they want to cut back supplies by 80% within a year. Other sources report over 66%. If Russia is subject to an oil and gas embargo, there is a risk that commodity prices in these areas will continue to rise significantly. Even the US is currently considering an import ban on Russian oil. Since then, there has been no stopping the oil price. The primary beneficiaries are the oil and gas producers, three of which we are taking a closer look at today.
Read
Commented by Armin Schulz on March 7th, 2022 | 13:05 CET
Valneva, Defence Therapeutics, MorphoSys - Blockbuster potential
Every pharmaceutical or biotech company wants a blockbuster. This term refers to a drug that generates annual sales of at least USD 1 billion. The best-known blockbuster drug currently is the Corona vaccine from BioNTech. In 2020, the rheumatism drug Humira was in the top spot with sales of over USD 20 billion. The Mainz-based vaccine manufacturer is likely to have significantly surpassed this mark in 2021. If a company hits the big time, it can reap the rewards for 20 years before the patent expires. Today, we take a look at three companies that have potential blockbusters.
Read
Commented by Armin Schulz on March 4th, 2022 | 12:33 CET
K+S, Phoenix Copper, Barrick Gold - Commodities as portfolio boosters
Prices for raw materials went through the roof last year. On the one hand, the global economy recovered faster than expected. On the other hand, demand for copper increased significantly, especially due to the turnaround in the automotive industry. Now, raw materials are becoming scarce again, as Russia is partially eliminated as an exporter of raw materials. It means that supply is lagging behind demand and resulting in rising prices. Especially for oil, gas and wheat, supply is expected to tighten significantly. Today we present three exciting commodity companies that could benefit from the crisis.
Read
Commented by Armin Schulz on March 2nd, 2022 | 11:24 CET
BioNTech, XPhyto Therapeutics, Valneva - Where are the Corona winners?
Even if the Corona coverage, which has prevailed for 2 years, has recently been replaced by the Ukraine conflict, the pandemic is not yet over. RKI chief Wieler recently reported increased outbreaks in nursing homes and rising incidences among the elderly. Health Minister Lauterbach also sees the wave not yet broken and reports the highest death rates in months. Since the legal basis for the Corona measures expires on March 19, a new law has been introduced to allow measures to be enacted beyond that date. Which companies could benefit?
Read